Scratching the surface: Exploratory analysis of key opinion leaders on rate limiting factors in novel adjuvanted-vaccine development
Keywords: CARG; compound annual growth rate; EPhMRA; European Pharmaceutical Marketing Research Association for the Anatomical Classification of Pharmaceutical Products; FDA; Food and Drug Administration; GSK; Glaxo Smith Kline; HBV; Hepatitis B Virus; HPV; Human P